Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West

Form 483 issued December 6, 2019 · Shizuishan, China

Inspection
Dec 2 – Dec 6, 2019
Observations
2
Pages
2
FEI number
3012375554

In short: On December 6, 2019, FDA issued a Form 483 with 2 observations to Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West in Shizuishan, Ningxia (FEI 3012375554) after an inspection that ran Dec 2 – Dec 6, 2019. The investigators were Jose M. Cayuela and Vincent Thomas. Most observations concern facilities & equipment and quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Facilities & equipment and quality system account for 2 of 2 observations.

Facilities & equipment1
Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    ot Tle § ; , Lye FAR tree = eee…

  2. 02

    fhe fda fotbd te APovosghly…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment and quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West?

Jose M. Cayuela and Vincent Thomas are named on this Form 483, for the inspection of Dec 2 – Dec 6, 2019. Each investigator has a profile showing what they cite most.

When was Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West inspected by FDA?

The inspection ran Dec 2 – Dec 6, 2019, and the Form 483 is dated December 6, 2019.

How do I get the full Form 483 for Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free